206 filings
10-Q
2024 Q1
ALBT
Avalon GloboCare Corp
Quarterly report
30 May 24
7:38pm
8-K
ALBT
Avalon GloboCare Corp
24 May 24
Avalon GloboCare Corp. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
5:10pm
NT 10-Q
ALBT
Avalon GloboCare Corp
15 May 24
Notice of late quarterly filing
8:00am
8-K
ALBT
Avalon GloboCare Corp
7 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
10-K
2023 FY
ALBT
Avalon GloboCare Corp
Annual report
15 Apr 24
5:08pm
NT 10-K
iy1hxc32jdf77v m5x7
1 Apr 24
Notice of late annual filing
4:30pm
8-K
6m6ebpf78v6 km
27 Mar 24
Entry into a Material Definitive Agreement
4:10pm
8-K
nipi5r cxqie
22 Nov 23
Entry into a Material Definitive Agreement
4:49pm
8-K
2qeyj6f8go8q 2ti
9 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
D
k82q v9l5m
20 Oct 23
$700.00 k in Convertible Debt, sold $700.00 k, 2 investors
4:18pm
8-K
mo3y 39j19siz6ru74j
13 Oct 23
Entry into a Material Definitive Agreement
4:30pm
8-K
usl 5tsnh8bd0tr
13 Oct 23
Departure of Directors or Certain Officers
9:15am
ARS
zka3mh8trgt2ff7udp
8 Sep 23
Annual report to shareholders
5:21pm
8-K
homl3zi
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
PRE 14A
763qgms7n
29 Aug 23
Preliminary proxy
4:55pm
8-K
mjyfwr3e4r6 l77o714
21 Aug 23
Avalon’s Laboratory Services MSO Announces Expansion into Arizona
9:11am
8-K
lvdkeqbahbppx
24 Jul 23
Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
9:05am